Commentary on: Abiraterone Plus Prednisolone in Metastatic, Castration-sensitive Prostate Cancer

被引：0
作者：
Struss, Werner J. [1 ]
Black, Peter C. [1 ]
机构：
[1] Univ British Columbia, Vancouver Prostate Ctr, Vancouver, BC, Canada
来源：
UROLOGY | 2017年 / 109卷
关键词：
THERAPY;
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1 / 2
页数：2
相关论文
共 50 条
  • [31] Adherence to abiraterone or enzalutamide in elderly metastatic castration-resistant prostate cancer
    Banna, Giuseppe L.
    Urzia, Valeria
    Benanti, Chiara
    Pitre, Alessandra
    Lipari, Helga
    Di Quattro, Rosario
    De Giorgi, Ugo
    Schepisi, Giuseppe
    Basso, Umberto
    Bimbatti, Davide
    Rundo, Francesco
    Libra, Massimo
    Malatino, Lorenzo
    SUPPORTIVE CARE IN CANCER, 2020, 28 (10) : 4687 - 4695
  • [32] Physician and Patient Preferences for the Treatment of Metastatic Castration-Sensitive and Castration-Resistant Prostate Cancer: A Best-Worst Scaling Study in Japan
    Kimura, Takahiro
    Takahashi, Noriko
    Asakawa, Keiko
    Saito, Atsushi
    Mitomi, Takeshi
    Lee, Takumi
    Matsumura, Mika
    ONCOLOGY AND THERAPY, 2025, 13 (01) : 217 - 232
  • [33] Effect of abiraterone acetate plus prednisone on the pharmacokinetics of dextromethorphan and theophylline in patients with metastatic castration-resistant prostate cancer
    Chi, K. N.
    Tolcher, A.
    Lee, P.
    Rosen, P. J.
    Kollmannsberger, C. K.
    Papadopoulos, K. P.
    Patnaik, A.
    Molina, A.
    Jiao, J.
    Pankras, C.
    Kaiser, B.
    Bernard, A.
    Tran, N.
    Acharya, M.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 71 (01) : 237 - 244
  • [34] A Phase 3 Trial With a 2x2 Factorial Design of Abiraterone Acetate Plus Prednisone and/or Local Radiotherapy in Men With De Novo Metastatic Castration-Sensitive Prostate Cancer: First Results of PEACE-1
    不详
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2021, 19 (08) : 6 - 7
  • [35] Attainment of early, deep prostate-specific antigen response in metastatic castration-sensitive prostate cancer: A comparison of patients initiated on apalutamide or enzalutamide
    Lowentritt, Benjamin
    Pilon, Dominic
    Khilfeh, Ibrahim
    Rossi, Carmine
    Muser, Erik
    Kinkead, Frederic
    Waters, Dexter
    Ellis, Lorie
    Lefebvre, Patrick
    Brown, Gordon
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2023, 41 (05) : 253.e1 - 253.e9
  • [36] Real-World Treatment Trends Among Patients with Metastatic Castration-Sensitive Prostate Cancer: Results from an International Study
    Barata, Pedro C.
    Leith, Andrea
    Ribbands, Amanda
    Montgomery, Rachel
    Last, Matthew
    Arondekar, Bhakti
    Ivanova, Jasmina
    Niyazov, Alexander
    ONCOLOGIST, 2023, 28 (09) : 780 - 789
  • [37] Combination Androgen Receptor Inhibition and Docetaxel in Metastatic Castration-sensitive Prostate Cancer: The Next Step in First-line Treatment?
    Adashek, Jacob J.
    Reed, Jarred P.
    Tandon, Ankita
    Freedland, Stephen J.
    Posadas, Edwin
    Bhowmick, Neil
    Chung, Leland W.
    Freeman, Michael
    Figlin, Robert A.
    Gong, Jun
    CLINICAL GENITOURINARY CANCER, 2020, 18 (06) : 425 - 428
  • [38] Efficacy and toxicity of abiraterone and docetaxel in octogenarians with metastatic castration-resistant prostate cancer
    Leibowitz-Amit, Raya
    Templeton, Arnoud J.
    Alibhai, Shabbir M.
    Knox, Jennifer J.
    Sridhar, Srikala S.
    Tannock, Ian F.
    Joshua, Anthony M.
    JOURNAL OF GERIATRIC ONCOLOGY, 2015, 6 (01) : 23 - 28
  • [39] Development and Validation of a Novel Prognostic Model for Predicting Overall Survival in Treatment-naive Castration-sensitive Metastatic Prostate Cancer
    Akamatsu, Shusuke
    Kubota, Masashi
    Uozumi, Ryuji
    Narita, Shintaro
    Takahashi, Masahiro
    Mitsuzuka, Koji
    Hatakeyama, Shingo
    Sakurai, Toshihiko
    Kawamura, Sadafumi
    Ishidoya, Shigeto
    Hoshi, Senji
    Ishida, Masanori
    Mizuno, Kei
    Ogura, Keiji
    Goto, Takayuki
    Terada, Naoki
    Kobayashi, Takashi
    Yamasaki, Toshinari
    Inoue, Takahiro
    Tsuchiya, Norihiko
    Ohyama, Chikara
    Arai, Yoichi
    Habuchi, Tomonori
    Morita, Satoshi
    Ogawa, Osamu
    EUROPEAN UROLOGY ONCOLOGY, 2019, 2 (03): : 320 - 328
  • [40] The Impact of Radiotherapy on the Primary Tumor in Patients with Metastatic High-Volume Castration-Sensitive Prostate Cancer: A Propensity Score Matching Analysis
    Skripai, Antoni
    Blumenfeld, Philip
    Krakow, Aaron
    Den, Robert
    Popovtzer, Aron
    Wygoda, Marc
    Michaeli, Tal Falick
    CANCERS, 2025, 17 (02)
12345